BRIEF published on 08/05/2026 at 15:01, 1 month 6 days ago Compagnie de l'Odet: Information for Shareholders as of July 31, 2026 Financial Information Voting Rights General Assembly Shares Issued Odet Company
BRIEF published on 08/05/2026 at 15:01, 1 month 6 days ago Compagnie de l'Odet : Informations aux Actionnaires au 31 Juillet 2026 Droits De Vote Assemblée Générale Information Financière Actions Émises Compagnie De L'Odet
PRESS RELEASE published on 08/05/2026 at 14:56, 1 month 6 days ago COMPAGNIE DE L'ODET : DECLARATION AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L’AUTORITE DES MARCHES FINANCIERS La Compagnie de l'Odet, société européenne, déclare ses chiffres clés au 31 juillet 2026 conformément à l'article 223-16 de l'AMF Déclaration AMF Société Européenne Chiffres Clés Compagnie De L'Odet
BRIEF published on 06/09/2026 at 15:43, 3 months 2 days ago Compagnie de l'Odet: Financial information as of May 31, 2026 Voting Rights Actions Financial Markets 2026 Odet Company
BRIEF published on 06/09/2026 at 15:43, 3 months 2 days ago Compagnie de l’Odet : Informations financières au 31 mai 2026 Droits De Vote Actions Marchés Financiers Compagnie De L'Odet 2026
PRESS RELEASE published on 06/09/2026 at 15:38, 3 months 2 days ago Compagnie de l’Odet : DECLARATION AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L’AUTORITE DES MARCHES FINANCIERS La Compagnie de l'Odet, société européenne, déclare ses chiffres clés au 31 mai 2026 conformément à l'article 223-16 du règlement général de l'AMF Déclaration AMF Société Européenne Chiffres Clés Compagnie De L'Odet
BRIEF published on 05/12/2026 at 10:02, 4 months ago Compagnie de l'Odet : Déclaration des Droits de Vote au 30 Avril 2026 Droits De Vote AMF Assemblée Générale Actions Émises Compagnie De L'Odet
BRIEF published on 05/12/2026 at 10:02, 4 months ago Compagnie de l'Odet: Declaration of Voting Rights as of April 30, 2026 Voting Rights AMF General Assembly Shares Issued Odet Company
PRESS RELEASE published on 05/12/2026 at 09:57, 4 months ago Compagnie de l’Odet : DECLARATION AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L’AUTORITE DES MARCHES FINANCIERS La Compagnie de l’Odet, société européenne, publie ses données financières au 30 avril 2026 conformément à l’Article 223-16 du règlement de l’AMF AMF Société Européenne Données Financières Compagnie De L’Odet 30 Avril 2026
BRIEF published on 04/08/2026 at 16:00, 5 months 3 days ago Compagnie de l'Odet : Déclaration des droits de vote au 31 mars 2026 Droits De Vote AMF Assemblée Générale Actions Émises Compagnie De L'Odet
Published on 09/12/2026 at 02:35, 10 hours 50 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 25 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 20 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 25 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 5 hours 54 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 10 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 14 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 40 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 9 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 17 hours ago Availability of the 2026 Interim Financial Report
